Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Glaxosmithkline (GSK) Share News

TOP NEWS: GSK completes demerger of healthcare product business

18th Jul 2022 08:32

(Alliance News) - GSK PLC on Monday confirmed it has completed the demerger of consumer healthcare business as Haleon PLC. Read More

LONDON MARKET PRE-OPEN: Euromoney takeover; Deliveroo cuts outlook

18th Jul 2022 07:50

(Alliance News) - Stock prices in London are seen opening higher on Monday, as Europe looks ahead to a key week on the political, monetary policy and energy market fronts. Read More

GSK consumer arm Haleon set to begin trading in London on Monday

15th Jul 2022 12:01

(Alliance News) - Haleon PLC, the consumer healthcare product arm of GSK PLC, will start trading on Monday, becoming effectively by far the biggest new listing in London in 2022, a poor year so far for initial public offerings. Read More

LONDON BROKER RATINGS: JPMorgan downgrades Admiral and Direct Line

15th Jul 2022 09:49

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday: Read More

IN BRIEF: GSK shareholders vote in favour of Haleon demerger

6th Jul 2022 19:20

GSK PLC - London-based pharmaceutical company - At general meeting, shareholders vote near unanimously in favour of proposed demerger of Haleon PLC from GSK, with the former's shares expected to list on the London Main Market at the open on July 18. Read More

IN BRIEF: Sareum notes updated payment terms after GSK buy of SRA737

4th Jul 2022 11:23

Sareum Holdings PLC - Cambridge, England-based drug developer for cancer and autoimmune diseases - Notes that GSK PLC has completed its acquisition of Sierra Oncology Inc, the licence holder of SRA737, for USD1.9 billion. SRA737 was discovered and initially developed by scientists at the Institute of Cancer Research in collaboration with Sareum. Read More

IN BRIEF: GSK completes acquisition of Sierra Oncology

1st Jul 2022 15:37

GSK PLC - London-based pharmaceutical company - Completes acquisition of Sierra Oncology Inc, for USD55 per share in cash, representing a total value of USD1.9 billion. Notes acquisition includes momelotinib, a late-stage potential treatment for myelofibrosis patients with anaemia. Last month, Sierra presented data for the treatment from phase III Momentum trial, which met all its key primary and secondary endpoints. The drug showed a statistically meaningful benefit on symptoms, splenic response, and anaemia. Read More

UK shareholder meetings calendar - next 7 days

29th Jun 2022 15:56

GSK seeks expanded approval for shingles vaccine in Japan

28th Jun 2022 08:41

(Alliance News) - GSK PLC on Tuesday announced it has submitted a regulatory application for Shingrix, a shingles vaccine, to the Japanese Ministry Health, Labour & Welfare. Read More

GSK posts positive interim results from hepatitis treatment trial

27th Jun 2022 06:27

(Alliance News) - GSK PLC on Saturday announced positive interim results from its B-Clear phase IIb trial, which tested bepirovirsen as a treatment of chronic hepatitis B. Read More

UK dividends calendar - next 7 days

24th Jun 2022 15:58

GSK and Sanofi tout positive vaccine results against Omicron

24th Jun 2022 06:51

(Alliance News) - GSK PLC and Sanofi SA on Friday reported positive results against the Omicron variant of Covid-19 from their vaccine in a placebo-controlled trial. Read More

TOP NEWS: GSK invests GBP1 billion to combat infectious diseases

23rd Jun 2022 12:21

(Alliance News) - GSK PLC on Thursday said it is investing GBP1 billion in research & development to fight infectious diseases like HIV and malaria in lower income countries over the next 10 years. Read More

TOP NEWS: Haleon to start trading in London on July 18 - FTSE Russell

15th Jun 2022 19:31

(Alliance News) - FTSE Russell on Wednesday said it expects Haleon, the Consumer Healthcare arm of GSK PLC, to commence trading on the London Stock Exchange on July 18. Read More

TOP NEWS: Sanofi, GSK booster jab impresses against Omicron

13th Jun 2022 08:52

(Alliance News) - Sanofi SA on Monday said its Covid-19 booster jab developed alongside GSK PLC delivers a stronger immune response to the Omicron variant than other jabs. Read More

LONDON BRIEFING: Pound hit as weak UK economy puts rate hikes in doubt

13th Jun 2022 08:18

(Alliance News) - The UK economy unexpectedly contracted again in April, leaving the Bank of England in a tough spot when it meets later this week. Read More

LONDON MARKET MIDDAY: Stocks down as investors await US inflation data

10th Jun 2022 12:17

(Alliance News) - Stock prices in London were lower at midday on Friday with market focus squarely on the upcoming US consumer price index report at 1330 BST. Read More

LONDON MARKET OPEN: GSK rises as RSV vaccine succeeds in trial

10th Jun 2022 08:57

(Alliance News) - Stock prices in London opened lower on Friday with trepidation ahead of US inflation data in the afternoon, while GSK bucked the market trend on upbeat late-stage trial results for a vaccine. Read More

TOP NEWS: GSK closer to first respiratory syncytial virus vaccine

10th Jun 2022 08:14

(Alliance News) - Drugmaker GSK PLC on Friday said its vaccine candidate for respiratory syncytial virus, or RSV, showed positive phase three data in older adults. Read More

LONDON MARKET PRE-OPEN: GSK get positive RSV vaccine trial results

10th Jun 2022 07:55

(Alliance News) - Equities in London are seen opening lower on Friday with investors cautious ahead of key US inflation data at 1330 BST. Read More

FTSE 100 Latest

Value9,539.71

Change12.06